Zontivity Co-Pay Assistance Coupon - Pack of 5

Zontivity Co-Pay Assistance Coupon - Pack of 5

Regular price
$0.00
Sale price
$0.00
Regular price
Sold out
Unit price
per 

Download Coupon and PI Here

INDICATIONS AND USAGE

ZONTIVITY is a protease-activated receptor-1 (PAR-1) antagonist indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or with peripheral arterial disease (PAD). ZONTIVITY has been shown to reduce the rate of a combined endpoint of cardiovascular death, MI, stroke, and urgent coronary revascularization (UCR).

IMPORTANT SAFETY INFORMATION

WARNING: BLEEDING RISK


-Do not use ZONTIVITY in patients with a history of stroke, transient ischemic attack (TIA), or intracranial hemorrhage (ICH), or with active pathological bleeding

-Antiplatelet agents, including ZONTIVITY, increase the risk of bleeding, including ICH and fatal bleeding

CONTRAINDICATIONS:

ZONTIVITY is contraindicated in patients with a history of stroke, TIA, or ICH because of an increased risk of ICH in this population. Discontinue ZONTIVITY in patients who experience a stroke, TIA, or ICH.

ZONTIVITY is contraindicated in patients with active pathological bleeding such as ICH or peptic ulcer.